NT Pharma (01011): Board Meeting Set for 31 Mar 2026 to Approve FY2025 Results and Final Dividend Proposal

Bulletin Express

03/18

China NT Pharma Group Company Limited (stock code: 01011) has scheduled a board meeting for Tuesday, 31 March 2026.

The agenda will cover: 1. Approval of the audited consolidated results for the financial year ended 31 December 2025. 2. Consideration of a final dividend recommendation for shareholders, if any.

The announcement was signed by Chairman Ng Tit on 18 March 2026 in Hong Kong. At the date of the notice, the Board comprises two executive directors (Ng Tit and Ng Anna Ching Mei), two non-executive directors (Dr. Qian Wei and Chin Yu), and three independent non-executive directors (Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Ng Ming Kwan).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1194903027"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194903027\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194903027?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 17:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194903027","market":"hk","top_or_hot":-1,"title":"NT Pharma (01011): Board Meeting Set for 31 Mar 2026 to Approve FY2025 Results and Final Dividend Proposal","media":"Bulletin Express","content":"<p>China NT Pharma Group Company Limited (stock code: 01011) has scheduled a board meeting for Tuesday, 31 March 2026.</p>\n<p>The agenda will cover:\n1. Approval of the audited consolidated results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders, if any.</p>\n<p>The announcement was signed by Chairman Ng Tit on 18 March 2026 in Hong Kong. At the date of the notice, the Board comprises two executive directors (Ng Tit and Ng Anna Ching Mei), two non-executive directors (Dr. Qian Wei and Chin Yu), and three independent non-executive directors (Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Ng Ming Kwan).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NT Pharma (01011): Board Meeting Set for 31 Mar 2026 to Approve FY2025 Results and Final Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNT Pharma (01011): Board Meeting Set for 31 Mar 2026 to Approve FY2025 Results and Final Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-18 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China NT Pharma Group Company Limited (stock code: 01011) has scheduled a board meeting for Tuesday, 31 March 2026.</p>\n<p>The agenda will cover:\n1. Approval of the audited consolidated results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders, if any.</p>\n<p>The announcement was signed by Chairman Ng Tit on 18 March 2026 in Hong Kong. At the date of the notice, the Board comprises two executive directors (Ng Tit and Ng Anna Ching Mei), two non-executive directors (Dr. Qian Wei and Chin Yu), and three independent non-executive directors (Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Ng Ming Kwan).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01011","symbol_name":"泰凌医药","start_time":0,"source_url":"","article_id":"1194903027","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194903027","pubTimestamp":1773824516,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China NT Pharma Group Company Limited (stock code: 01011) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda will cover: 1. Approval of the audited consolidated results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01011":"泰凌医药"},"translate_title":"泰凌医药(01011)：定于2026年3月31日召开董事会批准2025财年业绩及末期股息建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01011":1},"content_text":"China NT Pharma Group Company Limited (stock code: 01011) has scheduled a board meeting for Tuesday, 31 March 2026.\nThe agenda will cover:\n1. Approval of the audited consolidated results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders, if any.\nThe announcement was signed by Chairman Ng Tit on 18 March 2026 in Hong Kong. At the date of the notice, the Board comprises two executive directors (Ng Tit and Ng Anna Ching Mei), two non-executive directors (Dr. Qian Wei and Chin Yu), and three independent non-executive directors (Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Ng Ming Kwan).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}